JAK inhibitor

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10617690
APP PUB NO 20170360794A1
SERIAL NO

15545245

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention discloses a series of JAK inhibitors, and particularly discloses a compound of formula (I) or a pharmaceutically acceptable salt thereof and the use thereof in preparation of drugs for treating diseases related to JAK.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
WUXI FORTUNE PHARMACEUTICAL CO LTDXISHAN ECONOMIC ZONE WUXI JIANGSU 214000

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chen, Shuhui Shanghai, CN 339 290
Ding, Charles Z Shanghai, CN 109 845
Fan, Lili Shanghai, CN 9 21
Hu, Guoping Shanghai, CN 62 418
Li, Jian Shanghai, CN 1062 5232
Mao, Weiwei Shanghai, CN 19 84
Wang, Fei Shanghai, CN 1116 10607
Wu, Hao Shanghai, CN 930 3100

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Oct 14, 2027
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 14, 2031
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00